Biopsy: What Happens to a Sample

A biopsy provides a close look at cells or tissue, but it is still a sample rather than the whole organ. The laboratory prepares and examines it, sometimes using extra stains or molecular tests. Results can be definitive, uncertain or non diagnostic.

What a biopsy is A biopsy removes cells or tissue from the body so a laboratory can examine them. It may investigate cancer, inflammation, infection, organ disease or another abnormal process. A biopsy is not always needed to make a diagnosis. Clinicians recommend one when the expected information is likely to change care and the benefits justify the procedure's risks. The result answers a question about the submitted sample. It does not automatically describe every part of the abnormality or organ. Histology and cytology provide different information Histology examines pieces of tissue and preserves much of their architecture. Architecture means how cells and supporting structures are arranged together. Cytology examines individual cells or small groups of cells. The cells may come from a fluid, brushing, scraping or fine needle aspiration. A fine needle aspiration uses a thin needle to collect cells or fluid. A core biopsy uses a wider hollow needle to remove small cylinders of tissue. Core biopsy often provides more information about tissue architecture. Fine needle aspiration can still be the appropriate test for selected sites and questions. Samples can be taken in several ways A needle biopsy may be guided by ultrasound, mammography, CT or another imaging method. Image guidance improves targeting but cannot guarantee that every relevant part is sampled. An endoscopic biopsy is taken through a scope examining an internal surface. A punch biopsy removes a small cylinder of skin or another accessible tissue. An incisional biopsy removes part of an abnormality. An excisional biopsy removes the whole visible abnormality, although further treatment may still be required. The safest method depends on the site, suspected condition, sample needed and individual person. Consent should cover the important benefits, limitations, alternatives and procedure specific risks. Identification and clinical details matter The specimen container and request must identify the person and the exact biopsy site. This is especially important when several samples are collected. The laboratory also needs relevant clinical and imaging information. The same microscopic pattern can have different significance in different organs and clinical settings. These details help the pathologist decide how to process the sample, which additional tests may help and whether the findings explain the abnormality. What happens in the laboratory Many routine tissue biopsies undergo fixation, often in formalin. Fixation preserves tissue and reduces changes that would occur after removal. Laboratory staff inspect and measure the specimen. They process selected pieces, embed them in paraffin wax and cut very thin sections onto glass slides. A routine stain called haematoxylin and eosin makes tissue structures easier to see. A pathologist then examines the pattern of cells and tissue under a microscope or validated digital system. This pathway is not universal. Some cytology samples are spread onto slides, while selected specimens require fresh, frozen or specially preserved material. The clinical team and laboratory arrange the correct handling. You should not place a sample into another container or solution yourself. Additional tests can add information Special stains can highlight substances, microorganisms or tissue components. Immunohistochemistry uses labelled antibodies to detect selected proteins in cells or tissue. Molecular testing can examine DNA, RNA or other molecular features. These tests may help classify disease, identify an infection or predict whether a treatment is likely to work. Not every sample needs every test. Some small samples do not contain enough material for all possible analyses, so the laboratory must use tissue carefully. Selected samples can be examined rapidly during an operation using a frozen section. This gives limited immediate information and does not replace the final processed report. What a pathology report may say A pathology report may describe normal tissue, inflammation, infection, a benign abnormality, precancerous change, malignancy or another disease process. Reporting categories vary by organ and specimen type. Benign means non cancerous. A benign condition can still cause symptoms, grow locally or require treatment, and the finding must still match the clinical question. Malignant means cancer is present in the examined sample. The pathologist may report the cancer type, grade and treatment related biomarkers when the sample allows. Grade describes how the cancer cells and tissue look and can provide information about likely behaviour. Stage describes the cancer's extent and usually also needs imaging, examination, lymph node information or a larger surgical specimen. A biopsy report may be provisional while extra tests or expert review continue. The final report can add or amend information when those results become available. Not every biopsy gives a definite answer A non diagnostic result means the sample did not provide enough reliable information to answer the question. It does not mean that the tissue is normal. A sample may contain too little material, miss the target, become damaged or show an uncertain pattern. A lesion can also contain different areas, so a small sample may not represent the whole abnormality. Sampling error means the submitted material does not fully reflect the condition being investigated. It can produce false reassurance or an incomplete classification. Clinicians compare pathology with the examination, imaging and procedure findings. This is called clinicopathological concordance. A benign result that does not explain a suspicious scan should be reviewed rather than accepted automatically. The next step may be pathology review, repeat sampling, a different biopsy method, surgery or clinical follow up. Why results take different lengths of time Some results are available within several days, while others take one or more weeks. Timing varies with the specimen, workload, complexity and local service. Fixation, processing, additional stains, molecular testing, second opinions and multidisciplinary review can all extend the process. A longer wait does not reveal whether the result is benign or malignant. The service should tell you how and when results will be communicated. Contact the requesting team if the expected timeframe passes without an update. After the biopsy Common short term effects can include soreness, bruising or a small amount of bleeding. The exact risks depend on the body site and biopsy method. Follow the procedure specific advice about dressings, activity, medicines and when to seek help. Do not stop blood thinning medicines before or after a biopsy unless the responsible clinical team gives a plan. Contact the healthcare team or NHS 111 for worsening pain, fever, increasing redness or swelling, or blood or fluid continuing to ooze from the biopsy site. Call 999 for severe breathing difficulty, collapse or heavy bleeding that will not stop. This lesson explains general biopsy and pathology principles. It cannot interpret an individual report or decide whether a biopsy should be repeated.

A biopsy gives detailed information about submitted cells or tissue, but it remains a sample. Safe interpretation checks adequacy, representativeness, additional testing and agreement with the clinical and imaging findings.